Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Saskatchewan

$17,500.00

Cannabis and cannabinoid medications for the treatment of chronic orofacial pain

EF 2019-20

Résumé
"Cannabis and cannabinoid medications for the treatment of chronic orofacial painPeople suffering from chronic orofacial pain, persistent pain conditions affecting the head, mouth, and neck, often live with severe disability, and reduced quality of life. To compound the issue, current treatments can be expensive, cause unwanted side-effects, and are only modestly effective. Finding an additional means for treating these patients would be of significant benefit to them, and the specialists who deal with their cases.Cannabis and cannabinoid medications offer a promising alternative to conventional drugs used to treat chronic orofacial pain. Historical accounts and current literature support that cannabis has some effectiveness in treating chronic pain. The purpose of this study is to: 1. summarize current knowledge regarding treating chronic orofacial pain with cannabis and cannabinoid medications; and 2. identify clinician attitudes toward using these same medications to treat chronic orofacial pain. To achieve objective 1, a scoping review will be completed, collating current literature on the use of cannabis for treating chronic orofacial pain. To achieve objective 2, a survey regarding clinician attitudes toward using cannabis to treat chronic orofacial pain will be designed and distributed to oral surgeons and oral medicine specialists. The survey responses will be summarized and analyzed using statistical software.This review will create a resource for oral surgeons and oral medicine specialists seeking to inform their practice regarding the use of cannabis and cannabinoid medications. The survey will summarize the willingness of clinicians to use these medications for treatment of chronic orofacial pain, which may lead to the initiation of clinical trials."
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
Saskatchewan, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
428968
Name
Longworth Jory M
Region
Saskatchewan
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Cannabis and cannabinoid medications for the treatment of chronic orofacial pain
Programtype2
Studentship Programs
Orgnameinp2
University of Saskatchewan
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cannabidiol; Cannabis; Orofacial Pain; Temporomandibular Disorders
Abstract
"Cannabis and cannabinoid medications for the treatment of chronic orofacial pain</strong>People suffering from chronic orofacial pain, persistent pain conditions affecting the head, mouth, and neck, often live with severe disability, and reduced quality of life. To compound the issue, current treatments can be expensive, cause unwanted side-effects, and are only modestly effective. Finding an additional means for treating these patients would be of significant benefit to them, and the specialists who deal with their cases.Cannabis and cannabinoid medications offer a promising alternative to conventional drugs used to treat chronic orofacial pain. Historical accounts and current literature support that cannabis has some effectiveness in treating chronic pain. The purpose of this study is to: 1. summarize current knowledge regarding treating chronic orofacial pain with cannabis and cannabinoid medications; and 2. identify clinician attitudes toward using these same medications to treat chronic orofacial pain. To achieve objective 1, a scoping review will be completed, collating current literature on the use of cannabis for treating chronic orofacial pain. To achieve objective 2, a survey regarding clinician attitudes toward using cannabis to treat chronic orofacial pain will be designed and distributed to oral surgeons and oral medicine specialists. The survey responses will be summarized and analyzed using statistical software.This review will create a resource for oral surgeons and oral medicine specialists seeking to inform their practice regarding the use of cannabis and cannabinoid medications. The survey will summarize the willingness of clinicians to use these medications for treatment of chronic orofacial pain, which may lead to the initiation of clinical trials."
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Longworth, Jory M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~